Therapy activation ipnss
CPT code 93150 covers the activation and management of therapy during an inferior petrosal sinus sampling (IPNSS) procedure, typically used to diagnose Cushing's disease by testing hormone levels from veins near the pituitary gland.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
Billing tips
Verify whether facility or non-facility rate applies based on place of service; most IPNSS procedures occur in hospital outpatient settings (POS 22) qualifying for facility rate of $40.11
Impact: Incorrect POS coding can result in $57.90 overpayment/underpayment difference between facility and non-facility rates
Document the specific therapeutic agent used for activation (typically CRH or desmopressin) including dosage, timing, and rationale to support medical necessity
Impact: Lack of specific therapeutic activation documentation is the leading cause of denials; clear documentation prevents 100% payment loss
Bill 93150 in conjunction with the catheterization codes (36010, 36100, or 75870-75872) but verify payer bundling edits to determine if modifier 59 is needed
Impact: Unbundling without justification risks compliance issues; proper modifier use can preserve $40-98 in legitimate separate reimbursement
Coordinate billing between interventional physician and endocrinologist; ensure only one provider bills 93150 for the activation component to avoid duplicate billing
Impact: Duplicate billing triggers automatic denials and potential fraud investigation; clear provider assignment prevents recovery actions
Submit with detailed operative report documenting bilateral catheter placement, sampling times relative to therapeutic activation, and hemodynamic monitoring throughout
Impact: Complete procedural documentation reduces appeal time by 60-70% when medical review is triggered
Check LCD/NCD coverage policies for IPNSS procedures; some MACs require pre-authorization and specific ICD-10 codes (E24.0, E24.3, E24.8) to establish medical necessity
Impact: Pre-authorization compliance prevents 100% denial; wrong diagnosis code can trigger automatic rejection even with correct CPT
Common denials
Lack of documentation supporting therapeutic activation distinct from diagnostic sampling procedure
How to appeal: Submit detailed operative report highlighting specific therapeutic agent administration, dosing protocol, timing of activation relative to sampling, and medical rationale. Include endocrinology consultation notes supporting need for stimulation testing.
Bundling with catheterization or imaging codes (36000-36015 series, 75870-75872) without appropriate modifier
How to appeal: Provide NCCI edit reference showing 93150 is not bundled with primary procedure code, or demonstrate distinct session/encounter. If same session, append modifier 59 with documentation showing separate, medically necessary service.
Medical necessity denial when diagnosis code does not support IPNSS with therapeutic activation
How to appeal: Submit endocrinology workup documenting ACTH-dependent hypercortisolism (elevated 24-hour urinary free cortisol, elevated midnight salivary cortisol, abnormal dexamethasone suppression), equivocal imaging, and need for definitive localization. Include peer-reviewed literature supporting IPNSS as gold standard.
Duplicate billing when both interventionalist and endocrinologist submit 93150 for same procedure date
How to appeal: Withdraw duplicate claim and resubmit single claim from appropriate rendering provider with split billing arrangement documentation. Clarify roles: interventionalist performs catheterization/activation, endocrinologist may bill E/M or consult service separately.
Frequently asked questions
What is the Medicare reimbursement rate for CPT code 93150 in 2025?
The 2025 Medicare national average reimbursement for CPT 93150 is $98.01 for non-facility settings and $40.11 for facility settings. The work RVU is 0.85, with a total RVU of 3.03 using the 2025 conversion factor of 32.3465.
Can CPT 93150 be billed with catheterization codes on the same day?
Yes, CPT 93150 can be billed with catheterization codes (such as 36010 for introduction of catheter) on the same day when performing IPNSS procedures. However, verify NCCI edits and use modifier 59 if required by the payer to indicate a distinct procedural service. Documentation must clearly support both the catheterization and the separate therapeutic activation component.
What documentation is required to bill CPT 93150?
Required documentation includes the specific therapeutic agent used for activation (typically CRH), exact dosage and timing, bilateral catheter placement confirmation, sequential blood sampling times relative to stimulation, hemodynamic monitoring data, medical necessity justification, and the physician's interpretation. The operative report must clearly distinguish the therapeutic activation from routine diagnostic sampling.
Who can bill CPT code 93150?
CPT 93150 is typically billed by interventional radiologists, interventional cardiologists, neuroradiologists, or vascular surgeons who perform the catheterization and therapeutic activation during IPNSS procedures. The provider must have interventional privileges and fluoroscopy certification. Only one provider should bill 93150 per procedure to avoid duplicate billing issues.
What is the difference between facility and non-facility rates for CPT 93150?
The facility rate ($40.11) applies when the procedure is performed in a hospital outpatient department or ASC that provides equipment, staff, and supplies. The non-facility rate ($98.01) applies when performed in a physician's office where the provider incurs all overhead costs. The $57.90 difference reflects the practice expense component, with facility PE RVU of 0.34 versus non-facility PE RVU of 2.13.
Is prior authorization required for CPT 93150?
Prior authorization requirements vary by payer and Medicare Administrative Contractor (MAC). Many payers require pre-authorization for IPNSS procedures due to the specialized nature and cost. Check your MAC's Local Coverage Determination (LCD) and individual commercial payer policies. Documentation of failed conservative diagnosis and equivocal imaging typically supports medical necessity.
What are common denial reasons for CPT 93150 and how can they be prevented?
Common denials include lack of documentation supporting distinct therapeutic activation, bundling with catheterization codes without proper modifiers, medical necessity issues with diagnosis coding, and duplicate billing by multiple providers. Prevent denials by submitting detailed operative reports specifying the therapeutic agent and protocol, using appropriate modifiers (59 when needed), ensuring correct diagnosis codes (E24.x series), and coordinating single-provider billing.